Topoisomerase 2β mutation impairs early B-cell development
- Blood. 2020 Apr 23;135(17):1497-1501. doi: 10.1182/blood.2019003299.
Affiliations
- 1. Department of Medicine, University of Cambridge, Cambridge, United Kingdom.
- 2. Department of Molecular Cell Biology and Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- 3. Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, United Kingdom.
- 4. Great Ormond Street Hospital National Health Service Trust, London, United Kingdom.
- 5. University College London Genetics Institute, London, United Kingdom.
- 6. College of Applied Sciences, Al Baha University, Al Baha, Saudi Arabia.
- 7. University College London Institute of Immunity and Transplantation, London, United Kingdom.
- 8. Imagine Institute, University Paris Descartes Sorbonne Paris Cité, Paris, France.
- 9. INSERM UMR 1163, Paris, France.
- 10. Study Center for Primary Immunodeficiencies, Assistance Publique-Hôpitaux de Paris, Necker Hospital, Paris, France.
- 11. Department of Pediatric Immunology, Hematology and Rheumatology, Necker-Enfants Malades Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.
- 12. Collège de France, Paris, France.
- 13. Human Lymphohaematopoiesis Laboratory, INSERM UMR 1163, Paris, France; and.
- 14. Department of Immunology, Royal Free London NHS Foundation Trust, London, United Kingdom.
PMID: 32128574
DOI: 10.1182/blood.2019003299